Be the First to Access the Future of Cancer Prevention
Sign up for early access to miRoncol’s Real-time Multi-Cancer Early Risk Assessment, launching in early 2026 a new way to understand your cancer risk before symptoms appear.
Why Join Now
Cancer can develop quietly sometimes between regular checkups or imaging intervals. Annual follow-up testing helps identify molecular changes early, giving you and your physician more information to act on when it matters most.
By joining the list today, you’ll:
- Receive exclusive updates and launch information ahead of the public release.
- Learn how to access or purchase the test when it becomes available in your region.
- Be automatically entered to win a lifetime of annual miRoncol assessments helping you track your body’s molecular signals every year.
